http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-015985-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d9adaa7e7ce01ce8020f5c721aba10
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-702
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23J-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
filingDate 1998-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2001-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-015985-A1
titleOfInvention PHARMACEUTICAL COMPOSITIONS CONTAINING A 1,2-FUCOSE ALPHA LIGAMENT, A NUTRITION COMPOSITION, A SOLUTION FOR THE REHYDRATION, A VACCINE, A METHOD FOR THE TRACKING OF A COMPOSITION THAT PREVENTS THE ADHESION OF E. COLI OR V. CHOLERAE TO A RECOVERY GUEST CELL, A METHOD FOR RASTREARMIC
abstract Pharmaceutical compositions containing at least one fucose residue in an alpha 1,2 ligament and a pharmaceutically acceptable carrier.Specifically, such compositions may be employed in the treatment or prevention of gastrointestinal infections caused, for example, by Escherichia coli and Vibrio cholerae. The fucose residue comprises at least one fucose residue in an alpha 1,2 ligament is present in a compound selected from the group consisting of 2-fucosillactose, difucosillactose, Fucalfa1,2Galbeta1-4 [Fucalfa1-3] Glc, glycoproteins or glycopeptides containing the structure Fucalfa1-2Galbeta1-4Glc Nacbeta1-3 GM1-Fuc (Fucalfa1-2Galbeta-3GalNac), glycolipids and fucosylated derivatives of neutral glycolipids.In addition, it also includes a nutritional composition, a solution for rehydration, a vaccine, a vaccine for tracking a composition that prevents the attachment of E. coli or V. cholerae to a host cell receptor, a method of tracking pathogenic microorganisms from non-pathogenic microorganisms.
priorityDate 1998-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15559384
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413533255

Total number of triples: 19.